Extracellular matrix stiffness directs region-specific lung epithelial differentiation revealed by hPSC-derived lung organoids.

Summary

Using stiffness-tunable hydrogels, the authors demonstrate that ECM stiffness programs region-specific differentiation in hPSC-derived lung organoids: softening yields proximal-to-distal airway composition, whereas increased stiffness promotes AT2/AT1 maturation and AT2-to-AT1 transition. Mechanotransduction pathways mediate these effects, and the organoids recapitulate SARS-CoV-2 variant tropism.

Key Findings

• ECM stiffness governs region-specific differentiation in hPSC-derived lung organoids.
• Increased stiffness promotes AT2/AT1 maturation and drives AT2-to-AT1 transition.
• Mechanotransduction pathways mediate fate decisions; organoids reproduce SARS-CoV-2 variant tropism.

Clinical Implications

While preclinical, stiffness-tuned lung organoids offer a scalable model to study region-specific disease pathogenesis, optimize regenerative strategies, and evaluate inhaled therapeutics or variant-specific antiviral responses.

Limitations

• Preclinical in vitro model; in vivo validation of stiffness cues remains necessary
• Quantitative mapping of in vivo ECM stiffness across lung regions was not provided

Future Directions

Define in vivo stiffness landscapes across the human lung, couple organoids with vascular/immune compartments, and use the platform for precision testing of antivirals and regenerative therapies.